Appaneal, Haley J.
Shireman, Theresa I.
Lopes, Vrishali V.
Mor, Vincent
Dosa, David M.
LaPlante, Kerry L.
Caffrey, Aisling R.
Article History
Received: 19 January 2021
Accepted: 25 June 2021
First Online: 23 July 2021
Declarations
:
: The study was approved by the Institutional Review Board (IRB) and the Research and Development (R&D) Committee of the Providence Veterans Affairs Medical Center prior to initiation with a waiver of the informed consent process. All methods were carried out in accordance with relevant guidelines and regulations.This research was approved with a waiver of informed consent as the research involves no more than minimal tangible or intangible risk to the subjects; the waiver or alteration will not adversely affect the rights and welfare of the subjects; the research could not practicably be carried out without the waiver or alteration; and whenever appropriate, the subjects must be provided with additional pertinent information after participation.
: Not applicable.
: Haley Appaneal is supported in part by a Career Development Award, Department of Veterans Affairs and has received research funding from Shionogi.Theresa Shireman has no conflicts.Vrishali Lopes has no conflicts.Vincent Mor Chairs the Scientific Advisory Committee for naviHealth, a post-acute care convener serving MA plans and hospital systems.David Dosa has no conflicts.Kerry LaPlante has received research funding or acted as a scientific advisor for Merck, Ocean Spray, Pfizer, Allergan, Nabriva, and Paratek.Aisling Caffrey has received research funding from Pfizer, Merck, and Shionogi.All authors have funded projects from the Veterans Health Administration.